扩散MRI特征指数与浸润性乳腺癌免疫组化状态及分子亚型高度相关
回顾性研究纳入2017至2021年153例患者共160个浸润性乳腺癌灶,在3T MRI动态增强及三个b值(0、200、1500 s/mm²)DWI上计算特征指数(S-index),比较其均值及第85百分位值与免疫组化状态、增殖率及分子亚型的关系;结果显示S-index在雌激素受体阳性、孕激素受体阳性肿瘤中显著较高,在HER2阳性肿瘤中显著较低,不同分子亚型间差异显著;预测HER2的AUC分别为0.64和0.66,预测激素受体的AUC分别为0.70和0.74。
要点
- S-index均值及第85百分位值在ER阳性、PR阳性肿瘤中显著较高,在HER2阳性肿瘤中显著较低。
- S-index均值及第85百分位值在不同分子亚型间差异显著。
- 预测HER2的AUC分别为0.64和0.66,预测激素受体的AUC分别为0.70和0.74。
核心结论
- DWI S-index在免疫组化状态与良好预后相关的浸润性癌中显著较高,提示其可作为无创影像生物标志物用于评估免疫组化状态并指导治疗方向。
研究设计与样本
- 回顾性研究,纳入2017至2021年153例患者共160个浸润性癌灶,均行3T动态增强MRI及DWI(b值0、200、1500 s/mm²)并计算S-index,在DWI上手动勾画全肿瘤三维ROI。
诊断标准与关键数值
- S-index均值及第85百分位值预测HER2的AUC分别为0.64和0.66,预测激素受体的AUC分别为0.70和0.74。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the relationship of the signature index (S-index), an advanced diffusion MRI marker, and the immunohistochemical (IHC) status, proliferation rate, and molecular subtype of invasive breast cancers.
METHODS: A retrospective study of patients with invasive carcinoma was conducted between 2017 and 2021. All patients underwent dynamic contrast-enhanced MRI and DWI using a 3-T system. For DWI, three b values (0, 200, and 1500 s/mm2) were used to derive the S-index. Three-dimensional ROIs were manually placed over the whole tumor on DWI. Mean and 85th percentile S-index values were compared to the IHC status, proliferation rate, and molecular subtypes of lesions.
RESULTS: The study included 153 patients (mean age, 60 ± 13 years) with 160 invasive carcinomas. S-index values were significantly higher in estrogen receptor-positive (mean, p = .005; 85th percentile, p < .001) and progesterone receptor-positive (mean, p = .003; 85th percentile, p < .001) tumors, and significantly lower in human epidermal growth factor receptor 2 (HER2) - positive tumors (mean, p = .023; 85th percentile, p < .001). Mean and 85th percentile S-index values were significantly different among breast cancer subtypes (mean, p = .015; 85th percentile, p = .002), and the AUC of these values for the prediction of IHC status were 0.64 and 0.66 for HER2, and 0.70 and 0.74 for hormone receptors, respectively.
CONCLUSIONS: The DWI S-index showed significantly higher values in invasive carcinomas with immunohistochemical status associated with good prognosis, suggesting its usefulness as a noninvasive imaging biomarker to estimate IHC status and orient treatment.
KEY POINTS: • The signature index, an advanced diffusion MRI marker, showed good discrimination of immunohistochemical status in invasive breast carcinomas. • The signature index has the potential to differentiate noninvasively invasive breast carcinoma subtypes and appears as an imaging biomarker of prognostic factors and molecular phenotypes.
引用
- Goto, Le Bihan, Sakai, et al. The diffusion MRI signature index is highly correlated with immunohistochemical status and molecular subtype of invasive breast carcinoma. Eur Radiol. 2022. PMID: 35394179. doi:10.1007/s00330-022-08562-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。